METTL3 and neoplasm: This interesting result showed that METTL3 could be a tumor suppressor when its knockout could enhance sorafenib resistance, promote angiogenesis-associated genes expression, and activate pathway-associated autophagy in HCC cells under hypoxia condition (70).